Request for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W6QK ACC-APG

Contract Value

Not provided

Codes & Classification
Solicitation Number

W911SR-26-R-PPBC

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AN42

Additional Details
Set Aside

NONE

Place of Performance

Frederick, Maryland, UNITED STATES

SourceSAM
Documents2
The Department of the Army, through the W6QK ACC-APG contracting office, has issued a presolicitation notice inviting project proposals for the BEACON Program, specifically focused on Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management. This opportunity, identified by procurement number W911SR-26-R-PPBC, seeks to engage qualified organizations in advanced research and development activities within the biotechnology sector, as classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology). The primary objective of this procurement is to support the BEACON Program by facilitating the integration of medical countermeasure candidates and managing associated subcontractors. The intended outcomes include the seamless coordination and advancement of MCM candidates, ensuring that all research and development activities align with program goals and regulatory requirements. Contractors will be expected to demonstrate robust capabilities in both the scientific and administrative aspects of biotechnology R&D, with a particular emphasis on managing complex, multi-entity collaborations. Key requirements for this opportunity include expertise in biotechnology research and development, experience with medical countermeasure integration, and proven proficiency in subcontractor management. Deliverables are anticipated to encompass comprehensive project management plans, integration strategies for MCM candidates, and effective oversight mechanisms for subcontractor performance. While the specific details of the scope and deliverables are outlined in the attached Request for Project Pre-Proposal (RPP) document, interested parties should be prepared to address both technical and managerial components in their proposals. The place of performance for this contract is Frederick, Maryland, a location known for its concentration of biotechnology and defense-related research activities. The procurement is not subject to any set-aside restrictions, making it open to all qualified entities regardless of size or socioeconomic status. This presolicitation is classified under Product Service Code AN42, further indicating its focus on R&D in the life sciences domain. The contracting activity is managed by the Department of Defense, Department of the Army, with primary and secondary points of contact being Joseph McCaffery ([email protected]) and Alexander Mayatte ([email protected]), respectively. Interested contractors are encouraged to review the full RPP document, available via the provided SAM.gov link, for detailed instructions and requirements. The notice remains active, with a response deadline set for June 22, 2026. This opportunity represents a significant engagement for organizations with the requisite expertise in biotechnology R&D and project management, particularly those experienced in supporting federal medical countermeasure initiatives.